A detailed history of Penserra Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Penserra Capital Management LLC holds 33 shares of DXCM stock, worth $2,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 30 10.0%
Holding current value
$2,464
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $192 - $348
3 Added 10.0%
33 $2,000
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $200,684 - $246,155
-1,757 Reduced 98.32%
30 $4,000
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $29,290 - $48,174
-388 Reduced 17.84%
1,787 $221,000
Q3 2023

Nov 15, 2023

SELL
$86.06 - $137.93 $77,970 - $124,964
-906 Reduced 29.41%
2,175 $202,000
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $2.57 Million - $2.99 Million
-22,857 Reduced 88.12%
3,081 $395,000
Q1 2023

Apr 24, 2023

BUY
$104.0 - $122.92 $2.7 Million - $3.19 Million
25,918 Added 129590.0%
25,938 $3.01 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $1,699 - $2,453
20 New
20 $2,000
Q3 2020

Nov 13, 2020

SELL
$95.51 - $112.95 $1 Million - $1.19 Million
-10,513 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $641,091 - $1.08 Million
10,228 Added 3588.77%
10,513 $4.26 Million
Q1 2020

May 14, 2020

SELL
$47.79 - $75.63 $8,458 - $13,386
-177 Reduced 38.31%
285 $115,000
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $16,918 - $26,467
462 New
462 $109,000
Q3 2019

Nov 15, 2019

SELL
$35.53 - $43.8 $49,742 - $61,319
-1,400 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $38,976 - $54,488
1,400 New
1,400 $209,000
Q1 2019

May 08, 2019

SELL
$28.07 - $38.18 $20,210 - $27,489
-720 Closed
0 $0
Q4 2018

Feb 06, 2019

BUY
$26.99 - $37.37 $19,432 - $26,906
720 New
720 $86,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.